Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study
European Journal of Cancer · 2023
DOI: 10.1016/j.ejca.2023.02.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Joosje C Baltussen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. Hauptthemen laut MEDLINE: Breast Neoplasms, Cognitive Dysfunction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding.
Abstract (Originalsprache)
INTRODUCTION: Studies investigating the long-term effects of breast cancer treatment on cognition in older women with breast cancer are lacking, even though preserving cognition is highly valued by the older population. Specifically, concerns have been raised regarding the detrimental effects of endocrine therapy (ET) on cognition. Therefore, we investigated cognitive functioning over time and predictors for cognitive decline in older women treated for early breast cancer. METHODS: We prospectively enrolled Dutch women aged ≥70 years with stage I-III breast cancer in the observational CLIMB study. The Mini-Mental State Examination (MMSE) was performed before ET initiation and after 9, 15 and 27 months. Longitudinal MMSE scores were analysed and stratified for ET. Linear mixed models were used to identify possible predictors of cognitive decline. RESULTS: Among the 273 participants, the mean age was 76 years (standard deviation 5), and 48% received ET. The mean baseline MMSE score was 28.2 (standard deviation 1.9). Cognition did not decline to clinically meaningful differences, irrespective of ET. MMSE scores of women with pre-treatment cognitive impairments slightly improved over time (significant interaction terms) in the entire cohort and in women receiving ET. High age, low educational level and impaired mobility were independently associated with declining MMSE scores over time, although the declines were not clinically meaningful. CONCLUSION: Cognition of older women with early breast cancer did not decline in the first two years after treatment initiation, irrespective of ET. Our findings suggest that the fear of declining cognition does not justify the de-escalation of breast cancer treatment in older women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands.
- Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands; Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands.
- Mathematical Institute, Leiden University, Niels Bohrweg 1, 2333 CA Leiden, the Netherlands; Department of Biomedical Data Science, Medical Statistics Section, Leiden University Medical Center, Albinusdreef 2, 2333 ZA L…
- Department of Surgery, Groene Hart Hospital, Bleulandweg 10, 2803 HH Gouda, the Netherlands.
- Department of Medical Oncology, Reinier de Graaf Gasthuis, Reinier de Graafweg 5, 2625 AD Delft, the Netherlands.
- Department of Internal Medicine, LangeLand Hospital, Toneellaan 1, 2725 NA Zoetermeer, the Netherlands.
Förderung
- KWF Kankerbestrijding
Zitieren
APA
Baltussen, J. C., Derks, M. G. M., Lemij, A. A., de Glas, N. A., Fiocco, M., Linthorst-Niers, E. M. H., Vulink, A. J. E., van Gerven, L., Guicherit, O. R., van Dalen, T., Merkus, J. W. S., Lans, T. E., van der Pol, C. C., Mooijaart, S. P., Portielje, J. E. A., & Liefers, G. J. (2023). Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.02.008
Vancouver
Baltussen JC, Derks MGM, Lemij AA, de Glas NA, Fiocco M, Linthorst-Niers EMH, et al. Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.02.008
BibTeX
@article{Baltussen2023,
author = {Baltussen, Joosje C and Derks, Marloes G M and Lemij, Annelieke A and de Glas, Nienke A and Fiocco, Marta and Linthorst-Niers, Eugenie M H and Vulink, Annelie J E and van Gerven, Leander and Guicherit, Onno R and van Dalen, Thijs and Merkus, Jos W S and Lans, Titia E and van der Pol, Carmen C and Mooijaart, Simon P and Portielje, Johanneke E A and Liefers, Gerrit-Jan},
title = {Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study},
journal = {European Journal of Cancer},
year = {2023},
doi = {10.1016/j.ejca.2023.02.008}
}
EUVIMED